PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
03-Apr-2025 Drug of Abuse Testing Market to Witness 6.7% CAGR, Surpassing USD 12.46 Billion by 2033 Acumen Research and Consulting
03-Apr-2025 Gubra Welcomes New Board Members at 2025 AGM ACCESS Newswire
03-Apr-2025 Exousia Pro Issues Update on Name Change ACCESS Newswire
03-Apr-2025 Sleep Tech Devices Market Expected to Expand at 17.7% CAGR, Hitting USD 86,172 Billion by Acumen Research and Consulting
03-Apr-2025 Life Science Professionals say Agentic AI to Have Most Impact in Next 2-3 Years, but 51% Cite Resistance to Change as Biggest Barrier to Innovation The Pistoia Alliance
03-Apr-2025 Honeywell Unveils AI-Assisted Automation Platform To Transform Life Sciences Manufacturing Industry Honeywell
03-Apr-2025 AVEROA Receives Positive Opinion from the European Medicines Agency for XOANACYL®, an Oral Therapy for Chronic Kidney Disease (CKD) AVEROA
03-Apr-2025 CSL Behring and GKV-Spitzenverband Agree on Reimbursement Price for HEMGENIX® – Europe's First Gene Therapy for Haemophilia B CSL Behring
03-Apr-2025 Preclinical success for gene control system for Rett Syndrome Edinburgh Innovations
03-Apr-2025 PEPITEM sequence shows effects in psoriasis, comparable to steroid cream University of Birmingham
03-Apr-2025 Hansa Biopharma to host Q1 2025 interim results conference call Hansa Biopharma
03-Apr-2025 Akiram Therapeutics initiates Eurostars-funded collaboration to develop next-generation targeted alpha-therapeutics Akiram Therapeutics
03-Apr-2025 Elekta and Azra AI announce partnership to enhance cancer registry operations with AI-powered automation Elekta
03-Apr-2025 AlzeCure Pharma publishes its Annual Report for 2024 AlzeCure Pharma
03-Apr-2025 Cambridge Cognition selected for two Phase 3 trials combining digital cognitive and voice solutions Cambridge Cognition
03-Apr-2025 Phesi launches self-service Investigator Site Profiler solution to enhance precision of investigator site selection Phesi
03-Apr-2025 OncoZenge presents BupiZenge™ Phase 3 abstract at leading supportive cancer care conference in the US in June OncoZenge
03-Apr-2025 CSL Behring and GKV-Spitzenverband Agree on Reimbursement Price for HEMGENIX® – Europe's First Gene Therapy for Haemophilia B CSL Behring
03-Apr-2025 Novo Nordisk announces changes in Executive Management Novo Nordisk
03-Apr-2025 Stryker completes sale of U.S. spinal implants business Stryker